CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Shanghai Pharmaceutical Company Limited Company Snapshot
Shanghai Pharmaceutical Company Limited operates within the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Pharmaceutical Company Limited with three other companies in this sector in China: China National Accord Medicines Corporation Limited (2016 sales of 41.24 billion Chinese Renmimbi [US$6.09 billion] of which 75% was Distribution), China Medicine Health Industry Co Ltd (25.74 billion Chinese Renmimbi [US$3.80 billion] of which 67% was Pharmaceutical Business), and Jointown Pharmaceutical Group Co Ltd (61.55 billion Chinese Renmimbi [US$9.10 billion] of which 97% was Distribution).

Sales Analysis. During the year ended December of 2016, sales at Shanghai Pharmaceutical Company Limited were 120.76 billion Chinese Renmimbi (US$17.85 billion). This is an increase of 14.5% versus 2015, when the company's sales were 105.52 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Shanghai Pharmaceutical Company Limited (and since 2011, sales have increased a total of 120%). Sales of Distribution Segment saw an increase of 16.3% in 2016, from 90.20 billion Chinese Renmimbi to 104.86 billion Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Shanghai Pharmaceutical Company Limited
  Stock Performance Chart for Shanghai Pharmaceutical Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 26.79
(Figures in Chinese Renmimbi)
1 Week -1.1%   13 Weeks -2.0%  
4 Weeks 9.5%   52 Weeks 37.2%  
 
Shanghai Pharmaceutical Company Limited Key Data:
  Ticker: 601607 Country: China
  Exchanges: SHG Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2016 Sales 120,764,660,000
(Year Ending Jan 2017).
Employees: 40,852
  Currency: Chinese Renmimbi Market Cap: 72,035,898,900
  Fiscal Yr Ends: December Shares Outstanding: 2,688,910,000
  Share Type: A Gu Closely Held Shares: 1,066,300,881
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.